Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab® xPand and Gyrolab xPlore™), and peptide synthesis (PurePep® Chorus, Symphony® X and PurePep® Sonata®+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell & gene therapies and vaccines. Gyros Protein Technologies is a division of Mesa Laboratories.